Ligand validation:6SP8

B3P: 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

B3P is a Ligand Of Interest in 6SP8 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SP8_B3P_B_313	32%	53%	0.14	0.814	0.71	1.1	-	2	0	0	100%	0.82
6SP8_B3P_A_316	24%	49%	0.151	0.776	0.65	1.31	-	1	0	0	100%	0.86
6SP5_B3P_B_301	63%	52%	0.103	0.898	0.72	1.14	-	2	0	0	100%	1
6Y7D_B3P_B_902	99%	53%	0.048	0.975	0.77	1.06	-	1	1	0	100%	1
7AQ0_B3P_B_702	96%	40%	0.057	0.967	1.01	1.3	1	3	2	0	100%	1
6TJK_B3P_BBB_1927	95%	59%	0.066	0.97	0.53	1.03	-	1	0	0	100%	1
7AQ7_B3P_B_701	93%	48%	0.064	0.96	0.9	1.09	1	2	2	0	100%	1
7AQ3_B3P_B_1902	93%	44%	0.062	0.957	0.92	1.23	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.